166 related articles for article (PubMed ID: 3790968)
1. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC
Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion versus intermittent short infusion of metoclopramide for cisplatin-induced acute emesis.
Saito H; Shimokata K; Yamori S; Kajita M; Niimi T
Am J Clin Oncol; 1994 Oct; 17(5):422-6. PubMed ID: 8092115
[TBL] [Abstract][Full Text] [Related]
3. The effect of administration rate on cisplatin-induced emesis.
Jordan NS; Schauer PK; Schauer A; Nightingale C; Golub G; Martin RS; Williams HM
J Clin Oncol; 1985 Apr; 3(4):559-61. PubMed ID: 3884747
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
5. Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.
Agostinucci WA; Gannon RH; Golub GR; Martin RS; Schauer PK; Dinonno EB
Clin Pharm; 1988 Jun; 7(6):454-7. PubMed ID: 3402181
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intermittent versus continuous infusion metoclopramide in control of acute nausea induced by cisplatin chemotherapy.
Navari RM
J Clin Oncol; 1989 Jul; 7(7):943-6. PubMed ID: 2544688
[TBL] [Abstract][Full Text] [Related]
7. Comparison of continuous and intermittent bolus infusions of metoclopramide during 5-day continuous intravenous infusion with cisplatin.
Mori K; Saitou Y; Tominaga K; Yokoi ; Miyazawa N
Eur J Cancer; 1991; 27(6):729-32. PubMed ID: 1648944
[TBL] [Abstract][Full Text] [Related]
8. Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy.
Strum SB; McDermed JE; Opfell RW; Riech LP
JAMA; 1982 May; 247(19):2683-6. PubMed ID: 7043002
[TBL] [Abstract][Full Text] [Related]
9. Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation.
Strum SB; McDermed JE; Pileggi J; Riech LP; Whitaker H
Cancer; 1984 Mar; 53(6):1432-9. PubMed ID: 6692333
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial.
Malik IA; Khan WA; Qazilbash M; Ata E; Butt A; Khan MA
Am J Clin Oncol; 1995 Apr; 18(2):170-5. PubMed ID: 7900711
[TBL] [Abstract][Full Text] [Related]
11. Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis.
Roila F; Basurto C; Bracarda S; Sassi M; Lupattelli M; Picciafuoco M; Boschetti E; Tonato M; Del Favero A
Eur J Cancer; 1991; 27(2):119-21. PubMed ID: 1827271
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
Dana BW; McDermott M; Everts E; Abdulhay G
Am J Clin Oncol; 1987 Jun; 10(3):253-6. PubMed ID: 3296733
[TBL] [Abstract][Full Text] [Related]
13. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
[TBL] [Abstract][Full Text] [Related]
14. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
[TBL] [Abstract][Full Text] [Related]
15. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
[TBL] [Abstract][Full Text] [Related]
16. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
18. Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research.
Support Care Cancer; 1994 May; 2(3):167-70. PubMed ID: 8032702
[TBL] [Abstract][Full Text] [Related]
19. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
[TBL] [Abstract][Full Text] [Related]
20. Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide.
Senn HJ; Glaus A; Bachmann-Mettler I
J Clin Oncol; 1984 Apr; 2(4):320-2. PubMed ID: 6538593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]